Lori Muffly, Edward Abadir, Mark Geyer, Ryan Cassaday, Gregory Roloff, R. Alejandro Sica, Wendy Stock, Eileen McNulty, Maria del Rosario, Xiao Shi, Yanbo Liu, Yong Yu, Yali Zhou, Ming Gao, Wengang Ge, Lu Han, Yajin Ni, Jiangtao Ren, Jan Davidson-Moncada, Nitin Jain. "A single-arm, open-label, multi-center, phase 1b/2 Study to evaluate the safety, efficacy, and cellular pharmacokinetic profile of CTD402 in participants with relapsed/refractory T-cell acute lymphoblastic leukemia (T-ALL) and lymphoblastic lymphoma (T-LBL) (TENACITY-01)." Blood, 2025. doi:10.1182/blood-2025-5954